INDSWIFT LABORATORIES
Back to Balance Sheet
|
INDSWIFT LABORATORIES Last 5 Year Total Current Liabilities History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Total Current Liabilities | ₹257 Cr | ₹221 Cr | ₹221 Cr | ₹371 Cr | ₹334 Cr |
What is the latest Total Current Liabilities ratio of INDSWIFT LABORATORIES ?
| Year | Total Current Liabilities |
|---|---|
| Mar2026 | ₹257 Cr |
| Mar2025 | ₹221 Cr |
| Mar2024 | ₹221 Cr |
| Mar2023 | ₹371 Cr |
| Mar2022 | ₹334 Cr |
How is Total Current Liabilities of INDSWIFT LABORATORIES Trending?
| Years | Total Current Liabilities | % Change | |
|---|---|---|---|
| Mar2026 | ₹257 Cr | 16.64 | |
| Mar2025 | ₹221 Cr | -0.31 | |
| Mar2024 | ₹221 Cr | -40.37 | |
| Mar2023 | ₹371 Cr | 10.95 | |
| Mar2022 | ₹334 Cr | - | |
Compare Total Current Liabilities of peers of INDSWIFT LABORATORIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| INDSWIFT LABORATORIES | ₹2,981.7 Cr | -1.6% | -8.1% | 240.3% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹459,497.0 Cr | 8.1% | 9.3% | 9% | Stock Analytics | |
| DIVIS LABORATORIES | ₹294,146.0 Cr | 10.5% | 18% | 51.4% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹181,474.0 Cr | 2.9% | 2.1% | 30.7% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹114,349.0 Cr | -0.1% | 16% | 14.6% | Stock Analytics | |
| CIPLA | ₹113,989.0 Cr | 1.4% | 8.1% | -6.8% | Stock Analytics | |
INDSWIFT LABORATORIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| INDSWIFT LABORATORIES | -1.6% |
-8.1% |
240.3% |
| SENSEX | 7% |
11.5% |
-3.5% |
You may also like the below Video Courses